As featured in EMG Health publication 6th April 2020: https://www.emg-health.com/omnipresent/ability-to-stabilise-and-stockpile-covid-19-vaccine-is-vital/ A British breakthrough invention could form a crucial part in the urgent quest to combat Covid-19 and future virus pandemics. StablevaX™ allows vaccines to be transported and stored for years in a syringe without refrigeration, a unique capability. Currently, the World Health Organisation (WHO) estimates […]
Read More
Juana de la Torre Arrieta, with degrees in Molecular Biology and Biochemistry, recently joined the Stablepharma team as R&D Manager working closely with Dr Arcadio Garcia de Castro (Head of R&D). Both Arcadio and Juana are based in our R&D facility at Qube Technology Park in Madrid. From the point of entering the building, you […]
Read MoreFollowing the outstanding success of our recent £1.35m equity raise, StablePharma (www.stablepharma.com) is bringing a patented device to market that stands to significantly improve the way most vaccines are distributed globally, which will eliminate the current c. 50% wastage. Now, that we have our first clinical trials in humans underway, Stablepharma is delighted to announce […]
Read More